Actinium Pharmaceuticals, Inc. (ATNM) stock
Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –
Earnings
Actinium Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Actinium Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2015ended Jun 30, 2015 | Aug 3, 2015before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Actinium Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Actinium Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Actinium Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- News
- Update
- Update
- Update
- Update
See a number that looks wrong?